IDH1 and acute myeloid leukemia: The R132H substitution of IDH1 (Parsons et al., 2008; Mardis et al., 2009) and the R172K and R140Q substitutions of IDH2 (Ward et al., 2010) constitute the majority of mutational events and lead to the occurrence of GBM, AML, chondrosarcoma, cholangiocarcinoma, and angioimmunoblastic T-cell lymphoma (Cairns and Mak, 2013; Lu et al., 2013).